Towards regulatory endorsement of drug development tools to promote the application of model-informed drug development in Duchenne muscular dystrophy [Journal of Pharmacokinetics and Pharmacodynamics May 2019]
Posted byTerri Fettinger
This is a widget ready area. Add some and they will appear here.